Currently Open Funding Opportunities

Deadline	Title	Amount	Sponsored By	Research Area	Content
05/28/2026	Alzheimer's Association: Tau Pipeline Enabling Program V (T-PEP)	$750,000	Alzheimer's Association	Alzheimer's Disease, Drug Development, IND-Enabling Studies, Neurodegenerative disease, Tau, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due May 28, 2026 Amount: $750,000 (including 10% indirects) Project period: Two years Supports translational therapeutic development targeting tau-related mechanisms involved in Alzheimer’s disease and other tauopathies. The goal is to move promising therapies closer to clinical trials, bridging the gap between early discovery and IND-enabling development. Proposals responding to this program may focus on the toxicity of tau directly and/or they may target their studies on potential neurobiological mechanisms that promote or synergize tau formation or toxicity, e.g., calcium dyshomeostasis, mitochondrial dysfunction, neuroinflammation, microtubule stability (or instability) and function, axon transport, synapse dysfunction/loss, and other tau-related mechanisms. Applications addressing related mechanisms must include a clear rationale that it will prevent, reduce, remove, or otherwise mitigate the toxic effects of tau build-up. Funds awarded under this program must be used for development candidate selection, which includes activities directly supporting lead optimization, in vivo proof-of-concept, or IND-enabling studies, including cGMP scale-up/manufacture and animal efficacy studies. PI submits LOI through ProposalCentral.
05/10/2026	The Eisner Foundation: Eisner Prize Fellowship	$50,000	The Eisner Foundation	Intergenerational, Social	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due May 10, 2026 Amount: $50,000 (no indirects) Project period: One year Supports innovations in intergenerational connection, rather than existing programs. The strongest proposals introduce fresh programs, research, technology, or other innovations that intentionally connect different generations in new ways. Historically, efforts that actively foster connections during the Fellowship period have been most successful. Projects must be: Achievable within one year Executable by the Fellow themselves Realistic within a $40,000 budget An itemized budget is not necessary at the time of application, but the applicant should present a project scope that clearly reflects these limits. The Fellowship provides $50,000 total, split as follows: $10,000 stipend to the Fellow to be used however they wish; it should be disbursed in addition to the Fellow’s salary, not in partial replacement of it $40,000 for project execution to support new, clearly defined intergenerational projects, and ideally will exclude overhead costs
05/06/2026	Alzheimer's Association: HSR-ADRD program: Health Services Research	$250,000	Alzheimer's Association	Alzheimer's Disease, Dementia Care, Early Detection, Health Services	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due May 6, 2026 Amount is $250,000 (including 10% indirects) Project period: Two years This program supports health services research that improves how dementia care is delivered in real-world healthcare settings. Projects should generate actionable evidence that strengthens early detection, diagnosis, care coordination, and long-term management of Alzheimer’s disease and related dementias. Highly responsive topics include: Improving early detection and diagnosis of dementia Expanding access to biomarker-based diagnosis Strengthening care coordination and care pathways Developing person-centered and culturally responsive care models Reducing disparities in dementia care among underserved populations Improving transitions from diagnosis to long-term care support Engaging patients, caregivers, or communities in research design
06/30/2026	Harrington Discovery Institute: Brain Health Medicine	$100,000	Harrington Discovery Institute	Alzheimer's Disease, Biomarkers, Dementia, Neurodegeneration, Novel, Translational Research	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due June 30, 2026 Amount: $100,000 Project period: One year The Brain Health Medicines Scholar Award supports innovative therapeutic research aimed at treating, preventing, or curing Alzheimer’s disease and related dementias, with a strong emphasis on translational science and clinical impact. The program seeks projects that demonstrate rigorous and creative science, focus on novel, validated biological targets, and advance any therapeutic modality, including small molecules, biologics, gene therapies, or devices. Scholars receive up to $100,000 for one year, with the possibility of renewal for a second year based on milestone progress, along with a dedicated project manager and access to extensive drug development, commercial strategy, and business development expertise through the Harrington Therapeutics Development Center. Highly promising projects may qualify for up to $400,000 in additional funding and development support, making this program particularly attractive for investigators with strong translational concepts that could progress toward clinical application. Mark Humayun, MD, PhD won this award in 2014 with A Novel Treatment for Major Blinding Diseases.
05/14/2026	Robert Wood Johnson Foundation: Health Equity Research That Meets This Moment	$500,000	Robert Wood Johnson Foundation	Community Engagement, Health Equity, Indigenous Health, Policy, Racial Equity	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due May 14, 2026 Amount is $500,000 (including 15% indirects) Project period: Three years Applicants must demonstrate an established, authentic community partnership of at least two years (longer preferred). A community-based organization leader must serve as a co-PI, and only one organization may be the lead applicant (USC may serve as lead). The funder seeks systems-oriented, community-engaged research conducted in real-world settings and informed by community knowledge and lived experience. Projects should examine how policies, institutional structures, and power dynamics influence health outcomes and identify actionable leverage points to improve health equity. This program supports solution-focused research that advances racial and Indigenous health equity, moving beyond describing disparities to developing and testing interventions that address systemic inequities. Funded projects are expected to: Generate practical, actionable evidence Advance community-driven solutions Address root causes of inequities, including policy and structural barriers Strengthen community leadership and shared power in the research process The focus areas aim to strengthen the conditions that shape health by supporting safe housing, economic stability for families, inclusive governance, and trustworthy public health systems. They emphasize improving healthcare access, workforce diversity, and the use of data and community knowledge to advance health equity. The vision also includes promoting accurate, inclusive media and ensuring communities have the resources and voice needed to support healthy, thriving populations.
04/29/2026	The International Foundation: 2026 Program Grants for Health	$100,000	The International Foundation	Child Health, International, Maternal Health, Primary Care	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due April 29, 2026 Amount is $100,000 Project period: One year Supports community-based primary healthcare programs, with a strong focus on maternal and child health. Priority is given to initiatives that provide health education—particularly hygiene, family planning, and birth control—and expand healthcare access to remote and underserved regions while strengthening national health systems. Projects must be community-driven, scalable, and demonstrate measurable outcomes. This funder does not support biomedical research. Eligible organizations must be U.S.-based and implement programs serving low- and middle-income countries, primarily in Latin America and the Caribbean, Africa, and South and Southeast Asia and the Pacific. LOI portal is open until 150 LOIs have been received. The amount requested must represent less than 50% of the total project budget. Applicants must have a minimum of 25% of total project costs secured from other sources at the time of the application.
06/01/2026	American Cancer Society: Postdoctoral Fellowships	$70,000	American Cancer Society	Cancer, Post Doc	If you are interested in the following opportunity, please contact Amy Cook at [email protected]. Application Due: June 1, 2026 Amount: Increased progressive stipends of $66,000, $68,000, and $70,000 a year. Project Period: 3 years Postdoctoral Fellowships (PF) support new investigators in research training programs to position them for independent careers in cancer research. As part of their evaluation, peer reviewers consider how well the fellowship will broaden the applicant’s research training and experience. Potential applicants are eligible if they are a US citizen or a non-US citizen with an appropriate visa or lawful immigration status at the time of application, Are in a "postdoctoral" position at their institution. Applicants with a faculty appointment (instructor, assistant professor) or who are a research or staff scientist are not eligible. Have had a terminal doctoral degree for 3 years or less (time spent in clinical-only training is not counted) and/or completed 3 or fewer years of postdoctoral research training at the time of application.
06/01/2026	American Cancer Society: Institutional Research Grants	$480,000	American Cancer Society	Cancer, Early Career, Mid-career	If you are interested in the following opportunity, please contact Amy Cook at [email protected]. Application Due: June 1, 2026 Amount: $480,000 Project Period: 4 years Institutional Research Grants are awarded to institutions as block grants, providing seed money for newly independent investigators to initiate cancer research projects. The intent is to support these junior faculty in initiating cancer research projects so they can obtain preliminary results that will enable them to compete successfully for national research grants. You are eligible to submit a proposal as the IRG PI if you: Have the rank of Associate or Full Professor at an eligible institution, Demonstrate a track record of extramural cancer research funding and peer-reviewed publications Demonstrate a track record of mentoring junior investigators, Have significant administrative/leadership experience (i.e., deputy director/chair or director/chair of a program, center, or department).
06/01/2026	American Cancer Society: Research Scholar Grants	$660,000	American Cancer Society	Cancer, Clinician Scientist, Early Career, Health Equity	If you are interested in the following opportunity, please contact Amy Cook at [email protected]. Application Due: June 1, 2026 Amount: $660,000 (10% indirect costs) Project Period: 4 years Research Scholar Grants (RSG) provide support for independent, self-directed researchers and clinician scientists, who are investigators licensed to provide patient care and trained to conduct research. Applicants' institutions must provide space and other resources customary for independent investigators. Grant proposals are investigator-initiated and may pursue questions across the cancer research continuum, as long as they fit within an American Cancer Society (ACS) priority research areas. (Etiology, Obesity/Healty Eating and Active Living (HEAL), Screening and Diagnosis, Treatment, Survivorship Health Equity Across the Cancer Continuum Potential applicants are eligible if they are the PI on NO MORE than 1 R01 or R01-equivalent grant at the time of application (An R01-equivalent grant is defined by ACS as an award that is more than $100k direct costs per year for more than 3 years.) For new RSG applications - Were first appointed as independent, full-time faculty (or equivalent position) LESS than or equal to 8 years ago.
06/01/2026	American Cancer Society: Mission Boost Grants	$297,000	American Cancer Society	Cancer, Early Career, Established Investigator, Mid-career, Translational	If you are interested in the following opportunity, please contact Amy Cook at [email protected]. Application Due: June 1, 2026 Amount: $297,000 (10% indirects cost) Project Period: Two years Mission Boost Grants (MBG) are designed to support research projects that specifically focus on translation to human testing. MBGs are opportunities for independent investigators at all levels to apply for additional, or "boost," resources for innovative, clinical-enabling projects. MBGs offer 2 stages of funding: Stage I requires the investigator to develop outcome-specific, unequivocal milestones that reduce the risks of studying a new drug, device, or procedure in patients. Stage II supports testing in cancer patients. (Must have had to have a Stage I grant previously to be eligible) Applicants are eligibly if they are an independent investigator with a full-time faculty appointment (or equivalent). Applicants may be at any career stage.
06/29/2026	National Board of Medical Examiners (NBME): Stemmler Grants	$150,000	National Board of Medical Examiners (NBME)	Assessment, Medical Education Assessment, Performance Measurement	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due June 29, 2026 Amount is $150,000 Project period: One year The Stemmler Grant supports mid- and senior-career researchers who are developing innovative assessment methodologies or techniques in medical education or practice, including both pilots and more comprehensive projects. Collaborative investigations within or among institutions are eligible and encouraged. Teams are required to include one junior member. Competitive proposals focus on innovative assessment science, rather than general curriculum or education program evaluation. Projects that create new tools or methods tend to be more competitive than descriptive studies. Examples of responsive projects include: New methods to assess clinical reasoning or decision-making Innovative simulation-based or performance-based assessment models Development or validation of new assessment tools Technology-enabled assessment (e.g., AI-driven scoring, digital assessment platforms) Studies addressing fairness, equity, or bias in medical assessment Approaches to assess team-based or interprofessional clinical performance Projects are expected to advance theory, knowledge, or practical application of assessment, not simply measure learner satisfaction or teaching outcomes.
05/21/2026	ABIM Foundation: Medical Professionalism	$100,000	ABIM Foundation	Clinician Training, Clinician Well-being, Ethics, Health Equity, Medical Professionalism, System Level Improvement	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due May 21, 2026 Grants up to $100,000 (includes 10% indirects) Project period: Two years The ABIM Foundation Professionalism in Action Grant supports practical, implementation-focused projects that strengthen medical professionalism and trust between clinicians and patients, particularly in environments facing workforce stress, misinformation, and growing complexity in care. Grants are for the development and testing of real-world interventions, such as clinician communication training, patient education tools, professionalism curricula, or workflow innovations that improve compassionate, equitable, and patient-centered care. Competitive proposals emphasize measurable outcomes, scalability, and direct impact on patient experience or clinician practice, rather than traditional research alone. Recent funded projects illustrate the types of initiatives that are competitive: Development of trust-building communication training using standardized patient scenarios Training clinicians to teach patients correct medication or device use Community-engaged education models designed to improve patient understanding and trust Simulation-based training programs to improve clinician communication skills
05/15/2026	Wellcome Leap: Focused Antibiotics	$5,000,000	Wellcome Leap	AI Enabled Discovery, Antibacterial, Antibiotics, Antimicrobial Resistance, Artificial Intelligence (AI), Translational	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due May 15, 2026 Amount up to $5,000,000 (65% indirects) Project period: Three years The is a high-risk, milestone-driven initiative aimed at transforming antibiotic discovery—particularly against highly resistant bacteria—through bold, unconventional approaches and accelerated development models. The program responds to the global antimicrobial resistance (AMR) crisis by supporting projects that deliver step-change advances, not incremental improvements. Award amounts are dependent on specific proposals and work selected for funding. The budget should include full university overhead direct costs (supplies, equipment, salaries, depreciation, training, travel) and government-certified indirect costs appropriate to the execution of the research. There are no overhead or salary caps. Primary goals include: Discover new antibiotic classes or mechanisms of action Develop treatments effective against high-priority resistant Gram-negative pathogens Accelerate identification and validation of drug candidates Use novel tools, including AI-enabled discovery approaches Advance discoveries toward clinical translation This program differs from traditional investigator-initiated grants. It features milestone-based funding, rapid go/no-go decisions, coordinated multi-team collaboration, and a strong emphasis on measurable technical progress rather than publications alone. Competitive proposals typically: Target high-priority resistant pathogens Introduce novel biological or chemical strategies Include engineering, computational, or AI components Demonstrate a credible path to antibiotic candidates Show potential for measurable progress within defined timelines
06/05/2026	SPARK NS Translational Research Program	$2,000,000	Sparks NS	Autism, Drug Development, Parkinson's Disease, Therapeutic, Translational Research	If you are interested in the following opportunity, please contact Amy Cook at [email protected]. Full Application Due: June 5, 2026 Amount: Up to $2M over 2 years (10% Indirect Costs) This program is for principal investigators with projects focused on developing therapeutics for autism, Parkinson’s disease, and adjacent disorders. Selected projects will receive milestone-based funding of up to $2,000,000 and extensive support in all aspects of translational research and drug development. There is an option to submit information for an Optional Pre-Submission Review between now and May 12, 2026. Applicants from all backgrounds and experiences are encouraged to apply.
05/15/2026	Alliance for Cancer Gene Therapy	$500,000	Alliance for Cancer Gene Therapy	Cancer, Gene Therapy, Immunotherapy, Solid Tumor	If you are interested in the following opportunity, please contact Amy Cook at [email protected]. ACGT Investigator Award in Cell and Gene Therapy for SOLID TUMOR CANCERS Abstract Due: May 15, 2026 Full Application Due: September 1, 2026 Amount: Up to $500K over 2-3 years (10% Indirect Costs) Cell and gene therapy for solid tumors poses major challenges driven by antigen heterogeneity, physical exclusion, immunosuppressive microenvironments, genomic instability, and safety limitations. This RFA seeks innovative, translational cell and gene therapy strategies that directly address these barriers. Candidates for this award must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty or equivalent.
05/22/2026	Craig H. Nielsen Foundation	$400,000	Craig H. Nielsen Foundation	Neurorestoration, Spinal Cord Injury, Translational Research	If you are interested in the following opportunity, please contact Amy Cook at [email protected]. Spinal Cord Injury Research on the Translational Spectrum LOI Due: May 22, 2026 Full Application Due: November 12, 2026 Amount: $400K over 2-3 years (10% Indirect Costs) Supporting a wide range of research, the SCIRTS portfolio advances studies aimed at improving function, testing new treatment strategies, and moving them forward to improve outcomes for individuals with spinal cord injury (SCI). This portfolio supports creative, high-impact research that explores new interventions with the potential to restore function and promote wellbeing.
05/20/2026	Children’s Heart Foundation: Independent Research Awards	$300,000	Children's Heart Foundation	Cardiology, Clinical Research, Congenital Heart Disease, Pediatrics, Surgery, Translational Research	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due May 20, 2026 Amount: $300,000 (no indirects) Project period: Two years This program supports research that directly improves outcomes for patients living with congenital heart disease (CHD) across their lifetime. The foundation prioritizes clinical and translational research with strong potential to advance the diagnosis, treatment, and prevention of congenital heart defects. Studies in clinical cardiology—including surgical and interventional approaches—are especially encouraged. Projects that benefit large populations of CHD patients are highly valued. However, innovative studies with the potential to produce transformational impact, even for smaller patient populations, are also encouraged. Overall, clinical and translational applications are most competitive. Priority Research Areas (not limited to): Genetics and underlying causes of CHD Maternal health and modifiable prenatal factors affecting fetal CHD outcomes Fetal diagnosis and in-utero interventions Pharmacologic therapies Device development and procedural innovation (e.g., cardiac catheterization, cardiac surgery) Neurodevelopmental and functional outcomes Lifelong management of individuals living with CHD, including adult congenital care Emerging technologies and digital health solutions Quality improvement initiatives Health policy related to care delivery, coverage, and access Health disparities affecting CHD outcomes
04/28/2026	Adam Smith Panmure House Prize	$75,000	Panmure House	Economics, Innovation, Interdisciplinary	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due April 28, 2026 Amount: $75,000 (no indirects) Project period: Not defined Seeks to fund research projects that examine how long-term thinking and investment strategies drive radical innovation, particularly work that uses rigorous, interdisciplinary methods inspired by Adam Smith’s empirical approach. It is designed to support academic research that advances understanding of how sustained, long-term investment can enable transformative innovation with broad societal impact. Applications are scored against the following criteria: Prospective practical application of the research Originality and innovation of the contribution Disciplinary impact, including the influence of the candidate's research within their field and across interdisciplinary areas Potential for ongoing and future research Panmure House is a holding of Edinburgh Business School, Heriot-Watt University, Edinburgh, Scotland.
06/08/2026	National Institute for Health Care Management (NIHCM) Foundation: Policy Research Grants	$50,000	NIHCM Foundation	Affordability, Costs, Health Policy, Insurance Coverage	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due June 8, 2026 Amount: $50,000 (including 12% indirects) Project timeline: One year Supports investigator-initiated research that generates evidence to help policymakers, health plans, and health systems improve the affordability, access, and quality of U.S. health care. Projects are expected to produce actionable insights on rising health care costs and the organization, financing, or delivery of care, with findings that can inform real-world policy and decision-making.
05/04/2026	Vilcek Prize for Creative Promise in Biomedical Science	$50,000	Vilcek Foundation	Assistant Professor, Associate Professor, Basic Research, Basic Science, Early Career	If you are interested in this opportunity, please contact Karineh Petrossian at [email protected]. Application due: May 4, 2026 Amount: $50,000 Project period: One year Eligible applicants must be 38 years old or younger and have lived in the United States for a total of at least four years. Additionally, applicants must have earned a doctoral degree, hold a full-time tenure-track position at an academic institution or other organization, have co-authored at least one publication, and have at least one publication as a corresponding author.
06/17/2026	National MS Society: Understanding the Impact of Aging in Multiple Sclerosis	$200,000	National Multiple Sclerosis Society	Aging, Biomarkers, Comorbidities, Multiple Sclerosis, Pilot Research	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due June 17, 2026 Amount: $200,000 (plus 10% indirects) Project period: Two years Supports early-stage, feasibility, and developmental research that examines how aging influences the biology, progression, and management of multiple sclerosis (MS). The goal is to generate preliminary data and new insights that clarify how chronological and biological aging affect disease activity, disability, comorbidities, and treatment decisions, ultimately positioning investigators to compete for larger follow-on funding. Priority topics include studies on aging-related biological processes (such as immunosenescence and inflammaging) in MS, validation of biomarkers that distinguish MS-related changes from normal aging, characterization of disease trajectories and cognitive decline in older adults, and investigations into how age-related comorbidities influence MS outcomes and treatment safety. Projects unrelated to aging in MS, patient education programs, infrastructure development, or incremental extensions of existing work are not supported.
04/30/2026	University of Chicago: EPIC Air Quality Fund	$50,000	University of Chicago	Air Quality, National, Policy Impact	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due April 30, 2026 Amount: $50,000 Project period: 18 months The primary goal of these awards is to enable groups to achieve national-level policy impact through the generation, use, and open sharing of outdoor air quality data. Funding supports projects that establish long-term, stationary outdoor air quality monitoring networks, make resulting data publicly accessible, and disseminate findings within communities through activities that leverage these data. Projects focused on indoor air quality monitoring, mobile air quality monitoring, or wearable air quality monitors are not eligible for support. “National-level” policy impact refers to systemic changes in how air pollution is understood, measured, or addressed within a country, rather than nationwide mitigation efforts such as distributing masks or filters or increasing public awareness alone. Expected award amounts are approximately $50,000 for projects deploying lower-cost sensors and $75,000 or more for projects using regulatory-grade or reference-grade equipment.
05/06/2026	Alzheimer’s Association: Health Services Research in Alzheimer’s Disease and Related Disorders	$250,000	Alzheimer's Association	Alzheimer's Disease, Applied Research, Care Delivery, Caregiver Support, Diagnosis	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due May 6, 2026 Amount: $250,000 (including 10% indirects) Project period: Two years Supports applied research designed to improve how dementia care is delivered, particularly in ways that reduce disparities and improve access to timely diagnosis and high-quality care. Study Types Encouraged: Health services / health systems research Implementation science Care delivery models Access and utilization studies Diagnostic pathways and disparities research Not a fit for: Basic science Mechanistic biology Drug discovery The program focuses on real-world healthcare delivery challenges, such as improving early detection of ADRD, strengthening care coordination, expanding access to biomarker-based diagnosis, and developing culturally responsive care models for underserved populations. Projects are expected to generate actionable findings that can be implemented within healthcare systems and should include engagement with patients, caregivers, or communities affected by inequities in dementia care. This mechanism is intended for health services, implementation, and population health research rather than basic or laboratory science, making it especially well-suited for investigators studying barriers to diagnosis, disparities in care access, or innovative service delivery models that can improve outcomes for people living with ADRD. Applicants can be any career level, including postdoctoral fellow but must hold a full-time position at the time of the grant application submission.
06/15/2026	MNITF (Mendez National Institute of Transplantation): Research Grant Program	$150,000	Mendez National Institute of Transplantation Foundation	Diagnostics, Therapeutic, Transplantation	If you are interested in this opportunity, please contact Karineh Petrossian at [email protected]. LOI deadline: June 15, 2026 Full proposal due: July 31, 2026 Amount: $150,000 (10% indirects) Project period: Two years The MNITF funds research aimed to improve clinical outcomes and/or positively impact the field of organ transplantation. They prioritize projects that could make a significant, immediate impact on advancing transplantation and for which funding is not available from other sources.
06/01/2026	Rainin Visionary Scientist Award	$300,000	Kenneth Rainin Foundation	Crohn’s Disease, Early Career, Fellowship, Inflammatory Bowel Disease, Postdoctoral, Ulcerative Colitis	If you are interested in this opportunity, please contact Karineh Petrossian at [email protected]. Application due: June 1, 2026 Amount: $300,000 (no indirects) Project period: Two years By supporting promising scientists early in their careers, the Foundation seeks to advance discoveries that may ultimately improve the lives of people living with Crohn’s disease and ulcerative colitis.
06/16/2026	Helen Hay Whitney Foundation: Postdoctoral Fellowships	$229,000	Helen Hay Whitney Foundation	Basic Science, Fellowship, Postdoctoral	If you are interested in this opportunity, please contact Karineh Petrossian at [email protected]. Application due: June 16, 2026, 5PM EST Amount: $229,500 Project period: Three years One postdoc application per laboratory Foundation grants financial support to help further the careers of postdoctoral fellows in biological or medical research.
04/28/2026	American Diabetes Association: Advancing Innovative Research to Transform Outcomes in Type 1 Diabetes, Innovative Basic Science Award	$345,000	American Diabetes Association	Basic Research, Diabetes, Type 1 Diabetes	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 28, 2026 Amount: $345,000 (including 10% indirects) Project period: Three years Supports basic research with novel and innovative hypotheses in any area relevant to the etiology or pathophysiology of diabetes and its complications that holds significant promise for advancing the prevention, cure, or treatment of diabetes. Priority areas include research on Type 1 diabetes (T1D) disease mechanisms and prevention, stem cell and islet-based therapies, and treatments that delay or modify disease progression. Applicants must hold a full-time independent faculty position.
04/28/2026	American Diabetes Association: Advancing Innovative Research to Transform Outcomes in Type 1 Diabetes, Innovative Clinical or Translational Science Award	$600,000	American Diabetes Association	Diabetes, Human Studies, Type 1 Diabetes	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 28, 2026 Amount: $600,000 (including 10% indirects) Project period: three years Supports research with novel and innovative hypotheses performed in human subjects, or research approaches to accelerate the transition of scientific discoveries into clinical application. Studies supported with these awards must directly involve human subjects, human samples and/or data, and offer considerable promise for advancing the cure, prevention, or treatment of diabetes. Priority areas include research on Type 1 diabetes (T1D) disease mechanisms and prevention, stem cell and islet-based therapies, and treatments that delay or modify disease progression. The American Diabetes Association also emphasizes clinical and translational studies of new therapeutics and technologies, investigations into understudied complications (such as cognitive or neuropathic effects), and research addressing access to diabetes technologies and health inequities. Additional priorities include strategies to improve real-world care delivery, coordination across care settings, and outcomes for underserved populations. Applicants must hold a full-time independent faculty position.
04/28/2026	American Diabetes Association: Advancing Innovative Research to Transform Outcomes in Type 1 Diabetes Junior Faculty Development Award	$414,000	American Diabetes Association	Diabetes, Early Career, Type 1 Diabetes	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 28, 2026 Amount: $414,000 (including 10% indirects) Project period: Three years Supports innovative research that advances the understanding, prevention, treatment, or cure of Type 1 diabetes (T1D), with a clear pathway to improving patient outcomes, reducing treatment burden, or transforming disease management. The American Diabetes Association encourages projects across the full research spectrum—from discovery to real-world implementation—especially those that promote inclusive participation and leverage existing datasets or clinical resources. Priority areas include disease mechanisms and prevention, stem cell and cell-based therapies, disease-modifying treatments, clinical and translational studies, understudied complications, technology access and utilization, and strategies to strengthen care delivery and reduce health inequities. Applicants must hold a full-time independent faculty position up to and including Assistant Professor. The applicant should have no more than ten (10) years of research experience following receipt of their terminal degree. Principal Investigator must agree to devote at least 75% of their total time and overall effort towards research during the period of Association funding. This percentage includes time dedicated to the Association-funded grant in addition to grants supported by other funding agencies.
05/20/2026	Children's Heart Foundation: Independent Research Awards	$300,000	Children's Heart Foundation	Clinical Cardiology, Congenital Heart Disease, Fetal Health, Surgery	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 20, 2026 Amount: $300,000 (no indirects) Project period: Two years Supports research focused on congenital heart disease (CHD), including genetics, maternal and fetal health, fetal diagnosis and intervention, pharmacology, surgical and device development, neurodevelopmental outcomes, lifelong CHD care, technological innovation, quality improvement, health policy, and health disparities. The foundation prioritizes clinical and translational studies with the potential to benefit large patient populations or achieve transformational impact. Each principal investigator may submit only one application per grant cycle.
04/28/2026	Arthritis Foundation: 2026 Rheumatoid Arthritis Research Program	$450,000	Arthritis Foundation	Arthritis, Autoimmunity, Immunology, Inflammation, Rheumatoid Arthritis, Rheumatology	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 28, 2026 Pilot Research Award: Up to 2 years; up to $150,000 total (inclusive of 8% indirect costs) Large Research Award: Up to 3 years; up to $450,000 total (inclusive of 8% indirect costs) Research should seek to better understand and predict the development, progression, and treatment response of Rheumatoid Arthritis (RA). This includes applications focused on investigating the conversion of pre-RA to clinical RA, disease progression, and treatment response and safety. Competitive projects should aim to define mechanisms, risk factors, or biomarkers of conversion of pre-RA to clinical RA, disease progression, treatment response, pathogenic mechanisms, and/or therapeutic approach personalization. Not accepting applications focused on: Preclinical models without connection to clinical data or samples. Proposals focused solely on creating biobanks or creating/growing patient cohorts without inclusion of experimental work relevant to the scientific topics of interest above. Proposals focused on non-RA forms of arthritis. Pilot Research Award: Projects aim to investigate a novel hypothesis with no preliminary data requirements. Budget of up to $75,000 per year for 2 years (up to $150,000 total per award inclusive of 8% indirect costs) Large Research Award: Projects require preliminary data. Budget of up to $150,000 per year for 3 years (up to $450,000 total per award inclusive of 8% indirect costs).
04/29/2026	Arthritis Foundation: 2026 Patient-Reported Outcomes (PROs)	$250,000	Arthritis Foundation	Arthritis, Dermatology, Immunology, Rheumatology, Shared Decision Making	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 29, 2026 Amount: $250,000 (including 8% indirects) Project period: Two years Seeks to advance the use of existing Patient Reported Outcomes (PROs) in shared decision-making during arthritis clinical care. Research projects may explore topics including identification of goals of treatment, monitoring disease activity over time and improved paradigms for communication, interpretation and use of PROs data. Applications focused on patient-reported outcomes (PROs) for descriptive studies, quality assessment or benchmarking, population monitoring or health policy, or development of new PROs or psychometric tools are not accepted.
05/19/2026	Arthritis Foundation: 2026 Psoriatic Arthritis (PsA) Research Program	$250,000	Arthritis Foundation	Arthritis, Dermatology, Immunology, Inflammatory Arthritis, Psoriatic Arthritis, Rheumatology, Translational Research	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 19, 2026 Amount: $250,000 (including 8% indirects) Project period: Two years Seeks research proposals that advance understanding and treatment of psoriatic arthritis (PsA), including studies that identify biomarkers, risk factors, disease mechanisms, and improved therapies. Projects using clinical samples and/or patient data, alone or combined with relevant animal studies, are strongly encouraged. Areas of interest include diagnostic and imaging biomarkers, factors driving conversion from psoriasis to PsA, prevention strategies for at-risk populations, treatments for inadequately controlled PsA, disease mechanisms with clinical relevance, and the impact and management of comorbidities. Interdisciplinary teams are encouraged, while projects limited to preclinical models, biobank creation without experimental work, or arthritis unrelated to psoriatic disease are not supported.
05/15/2026	Eastern Association for the Surgery of Trauma: Trauma Research Scholarship	$40,000	Eastern Association for the Surgery of Trauma	Burns, Early Career, Injury, Surgery, Trauma	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 15, 2026 Amount: $40,000 (no indirects) Project period: One year Supports early-career investigators conducting basic or applied trauma-related research, including projects in basic science, clinical care, epidemiology, injury prevention, or burns that show strong potential to generate preliminary data for future funding. Applicants must be within five years of completing residency or fellowship in trauma, acute care surgery, or critical care; be committed to an academic trauma research career; and be members of EAST. The award is intended for investigators who have not received NIH funding (other than NRSA) or similar career development awards, and recipients must obtain IRB or IACUC approval by July 1 of the funding year.
05/29/2026	Oberkotter Foundation: Hearing Habits to Optimize Device Wear Time	$500,000	Oberkotter Foundation	Caregiver, Hearing, Hearing Device, Listening and Spoken Language, Pediatric Audiology	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due May 29, 2026 Amount: up to $500,000 (15% indirects) Project period: Up to three years Supports projects that increase consistent hearing device use during all waking hours in infants and young children who are deaf or hard of hearing, helping them achieve age-appropriate spoken language and literacy milestones. Funding is intended for implementation of new, adapted, or expanded programs and for generating practical insights on effective tools and strategies. Competitive proposals should include: Implementation: Clear methods for launching or expanding family-centered programs that promote consistent device use, including risk mitigation and monitoring plans. Impact: Measurable goals and a plan to track progress toward hearing device wear-time targets. Baseline data is optional. Project Costs: A budget management plan with attention to long-term sustainability beyond the grant period. Not supported: Projects lacking direct services or solutions benefiting children and families Counseling or family support without a clear focus on device use Educational materials duplicating those already available through Hearing First (an initiative of the Oberkotter Foundation) Funding amount: No stated minimum or maximum award size. $500,000 is a midrange for prior grants from this funder.
06/22/2026	Michelson Medical Research Foundation: Michelson Prizes: Next Generation Grants	$150,000	Michelson Medical Research Foundation	Early Career, Human Immunology, Immunology, Immunotherapy, Vaccines	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due June 22, 2026 Amount: $150,000 Project period: One year Seeks disruptive research concepts and inventive processes to significantly advance the discovery of vaccines and immunotherapies for major global diseases. Early-career researchers across scientific disciplines—including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, and nanotechnology—are encouraged to apply. Eligible applicants must be age 35 or younger and may include early-career investigators, postdoctoral fellows, clinical fellows (including residents and interns), doctoral students, and other trainees in research positions. Award recipients must commit at least 50% of their full-time professional effort to the funded research throughout the award period.
04/30/2026	Elsa U. Pardee Cancer Research Award	$200,000	Elsa U. Pardee Foundation	Cancer, Early Career, Oncology, Post Doc	If you are interested in applying to this opportunity, please contact Amy Cook at [email protected]. Full Application Due: April 30, 2026 Amount: Between $100,000 and $200,000 (no more that 5% Indirect costs) Project Period: 1 year This award funds research directed toward identifying new treatments or cures for cancer. The Foundation funds projects for a one-year period which will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment, or cure should be clearly identified. Faculty members who are still early in their careers, as well as new faculty members and postdocs, are preferred.
04/27/2026	One Mind: Rising Star Awards	$300,000	One Mind	Early Career, Mental Health, Neuroscience, Psychiatric Disorders	If you are interested in this opportunity, please contact Karineh Petrossian at [email protected]. Application due: April 27, 2026, 9:00PM PT Amount: $300,000 (20% indirect costs) Project period: three years Applicant eligibility The 2026 One Mind Rising Star Awards will support grant proposals spanning basic/preclinical, translational, and clinical research for psychiatric disorders. This program provides awardees with leadership training, networking and singular career development opportunities, and catalytic tools to serve as scientific thought leaders and transform the mental health ecosystem.
05/27/2026	PhRMA Foundation: Translational Medicine Postdoctoral Fellowship	$120,000	PhRMA Foundation	Artificial Intelligence (AI), Biomarker Validation, Early Career, Human-Relevant Models, Post Doc Fellows, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 27, 2026 Amount: $120,000 (no indirects) Project period: Two years Supports hypothesis-driven translational research that develops innovative diagnostics, therapies, precision medicine strategies, and computational or AI-enabled models to improve treatment for diseases with unmet clinical need. Projects must include human-relevant validation—such as clinical samples, datasets, or humanized models—and demonstrate clear therapeutic relevance, ideally developed in collaboration with clinicians. Studies must move beyond descriptive biology, include plans for validating computational or AI approaches, and avoid relying solely on animal models without human components. Applicants must be postdoctoral researchers who hold a PhD, MD, PharmD, or equivalent doctorate earned in 2024 or later, with at least two first-author publications. Applicants may not hold major individual awards (e.g., NIH K99/R00 or F awards) or other stipend-supporting funding during the fellowship, though those on institutional training grants may apply if they relinquish that support if funded. Preference is given to candidates training in a new laboratory, and only one applicant per lab may apply. This award is intended solely as a stipend and may not be used otherwise. Funds may not be used for tuition, fringe benefits, or indirect costs to the university.
05/27/2026	PhRMA Foundation: Translational Medicine Predoctoral Fellowship	$60,000	PhRMA Foundation	Artificial Intelligence (AI), Biomarker Validation, Early Career, Human-Relevant Models, Predoctoral, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 27, 2026 Amount: $60,000 (no indirects) Project period: Two years Supports hypothesis-driven translational research that develops innovative diagnostics, therapies, precision medicine strategies, and computational or AI-enabled models to improve treatment for diseases with unmet clinical need. Projects must include human-relevant validation—such as clinical samples, datasets, or humanized models—and demonstrate clear therapeutic relevance, ideally developed in collaboration with clinicians. Studies must move beyond descriptive biology, include plans for validating computational or AI approaches, and avoid relying solely on animal models without human components. Applicants must be full-time PhD students who have completed at least two years of coursework and are actively engaged in thesis research, with PhD completion expected after March 1, 2028. They must have at least one publication or poster, devote full time to research during the fellowship, and not hold other stipend-supporting awards (e.g., NIH-F). Students on institutional training grants may apply if they agree to relinquish that support if funded, and only one applicant per lab may apply. This award is intended solely as a stipend. Funds may not be used for tuition, fringe benefits, or indirect costs to the university.
05/27/2026	PhRMA Foundation: Translational Medicine Faculty Starter Grant	$100,000	PhRMA Foundation	Artificial Intelligence (AI), Biomarker Validation, Early Career, Human-Relevant Models, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 27, 2026 Amount: $100,000 (no indirects) Project period: One year Supports hypothesis-driven translational research that develops innovative diagnostics, therapies, precision medicine strategies, and computational or AI-enabled models to improve treatment for diseases with unmet clinical need. Projects must include human-relevant validation—such as clinical samples, datasets, or humanized models—and demonstrate clear therapeutic relevance, ideally developed in collaboration with clinicians. Studies must move beyond descriptive biology, include plans for validating computational or AI approaches, and avoid relying solely on animal models without human components. Applicants must be early-career, research-intensive faculty whose appointments began on or after January 1, 2025, and whose terminal degree was awarded in 2017 or later. They must be eligible for independent funding, have at least three first-author publications, and not hold major external grants (e.g., NIH R/K awards, NSF CAREER, or funding generally exceeding $250,000/year). Preference is given to investigators with limited startup funding (under $750,000), and only one applicant per lab may apply. Funds must be used to conduct the proposed research. Funds may not be used for salary support of the awardee, fringe benefits, or indirect costs.
05/15/2026	Eastern Association for the Surgery of Trauma (EAST): Trauma Research Scholarship	$40,000	Eastern Association for the Surgery of Trauma	Burns, Critical Care, Injury, Scholarship, Surgery	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI deadline: May 15, 2026 Amount: $40,000 (no idirects) Project period: One year Supports basic or applied trauma-related research. Eligible projects include but are not limited to basic science, clinical, epidemiology, injury prevention, and burns. Applicants must be within five years of completing their residency or fellowship in trauma, acute care surgery, or critical care. Membership in EAST is required for application.
05/01/2026	Internal Funding Opportunity: The Nemirovsky Engineering and Medicine Opportunity (NEMO) Prize	$125,000	University of Southern California	Collaboration, Engineering, Health Sciences, Research	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI Due: May 1, 2026 Amount is: $125,000 Project Period: Multiple Years The Nemirovsky Engineering and Medicine Opportunity (NEMO) Prize is now accepting Letters of Intent for its final funding cycle, and two awards of $125,000 each are up for grabs. Open to faculty and research investigators at USC and Children's Hospital Los Angeles, the prize supports early-stage, collaborative projects at the intersection of health sciences and engineering that are not yet ready for federal funding or private investment. Past recipients have tackled cutting-edge challenges including pediatric brain tumors and AI-directed personalized medicine for leukemia, demonstrating the transformative potential of health-engineering partnerships at USC.
04/24/2026	American Tinnitus Association: Postdoctoral Fellowship	$40,000	American Tinnitus Association	Early Career, Hearing, Postdoctoral, Tinnitus, Training	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due April 24, 2026 Amount is $40,000 (no indirects) Project period: One year Supports doctoral-level students conducting dissertation research focused on tinnitus. Applicants must be enrolled full-time in a U.S.-accredited doctoral program and work under the supervision of an experienced tinnitus researcher with active external funding.
04/24/2026	American Tinnitus Association: U.S. Pilot Data Grant (Early Career)	$25,000	American Tinnitus Association	Early Career, Hearing, Pilot Data, Tinnitus	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due April 24, 2026 Amount is $25,000 Project period: One year Supports junior investigators whose tinnitus research requires acquisition of pilot data, or experienced scholars seeking to build a research portfolio related to tinnitus.
04/24/2026	American Tinnitus Association: Translational/Clinical Research Grant	$200,000	American Tinnitus Association	Biomarkers, Clinical, Hearing, Tinnitus, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due April 24, 2026 Amount is $200,000 (plus $20,000 indirects) Project period: Two years Supports the collection of original data in human participants. Applications may emphasize the development of new biomarkers for the objective assessment of tinnitus. Alternatively, applications may propose research into novel interventions for tinnitus relief.
04/24/2026	American Tinnitus Association: Foundational Research Grants	$200,000	American Tinnitus Association	Animal Model, Biological Targets, Hearing, In Silico Model, Tinnitus, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due April 24, 2026 Amount is $200,000 (plus $20,000 indirects) Project period: Two years Supports investigation into the fundamental mechanisms of tinnitus and the identification of biological targets with translational potential in animal or in silico models.
06/15/2026	American Surgical Association Foundation: Fellowship Research Awards	$75,000	American Surgical Association Foundation	Academic Surgery, Early Career, Fellowship, Research, Surgeon	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due June 15, 2026 Amount: $75,000 (no indirects) Project period: One year (with possible renewal) During the fellowship, the Fellow is expected to focus primarily on research and teaching and to transition to a faculty position in the Department of Surgery at the sponsoring institution. Applicants must apply within five years of completing residency or fellowship training, must not have received $150,000 or more in independent funding, and must have support from both a primary mentor and department chair.
04/30/2026	McKesson Foundation: Student Engagement	$25,000	McKesson Foundation	Career, Community, Education, Oncology Workforce, Pharmacy Workforce, Student Pathways	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due April 30, 2026 Amount is $25,000 Project period: not determined Must have a national (not local) focus. Focus Areas: Oncology Workforce: Strengthen recruitment and retention while improving cultural competency to better serve diverse patients. Pharmacy Workforce: Expand and prepare pharmacists and technicians for provider roles, leveraging their community trust to support vulnerable populations. Student Pathways: Build early pipelines that engage youth and guide them into healthcare education and careers.
05/01/2026	RRF Foundation for Aging: Research Grant	$200,000	RRF Foundation for Aging	Aging, Interventional, Policy, Translational	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 1, 2026 Amount: up to $200,000 (10% indirects) Project period: Up to two years RRF supports research that improves the well-being of older adults and their caregivers, with an emphasis on practical, actionable findings for policy, practice, and advocacy. Priority is given to interventional, translational, and health services or policy studies that build on prior work and include strong dissemination plans to ensure impact.
05/06/2026	National Multiple Sclerosis Society: Career Transition Fellowship	$650,000	National Multiple Sclerosis Society	Early Career, Multiple Sclerosis, Postdoctoral	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 6, 2026 Amount: $650,000 Project period: Five years The award provides up to $650,000 over five years to support a two-year period of advanced postdoctoral training in MS research and the first three years of research support in a new faculty appointment. The Fellowship targets current postdoctoral trainees who demonstrate both commitment to conduct MS-related research. Applicants must hold a doctoral degree (M.D., Ph.D. or equivalent) and must be in research-oriented postdoctoral training. Applicants must have more than two years of postdoctoral research experience and no more than five years of postdoctoral research experience at the time of application.
05/12/2026	Cystic Fibrosis Foundation: Pilot and Feasibility Awards	$100,000	Cystic Fibrosis Foundation	Cystic Fibrosis, Early Career	If you are interested in this opportunity, please contact Carole King at [email protected]. Application due: May 12, 2026 Amount: $100,000 (plus 12% indirects) Project period: Two years Supports early-stage, hypothesis-driven and innovative research in cystic fibrosis, particularly for new investigators. Projects should focus on understanding disease mechanisms or developing prevention and treatment strategies. Clinical interventional studies and CFTR-focused therapies should apply through separate, specialized funding programs.
04/30/2026	The Donaghue Foundation: Greater Value Portfolio 2026	$500,000	Donaghue Foundation	Health Disparities, Healthcare Costs, Low-Value Care, Quality of Care, Value-Based Decision Making	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 30, 2026 Amount: $500,000 (plus 10% indirects) Project period: Two years Supports research that addresses the symptoms of low-value healthcare, including rising costs, unwarranted price variation, racial and ethnic disparities, financial burdens on patients, inconsistent care quality, and lack of transparency in pricing and outcomes. The goal is to support actionable solutions that improve quality, efficiency, equity, and affordability in healthcare delivery. Proposed projects should evaluate or redesign existing care models to reduce inefficiencies and costs, limit unnecessary tests or treatments that provide little benefit, and develop tools that help patients make value-based healthcare decisions. Competitive proposals will also promote clearer patient-provider communication about treatment trade-offs and support interventions that expand equitable access, improve care consistency, and align healthcare pricing with the value of services provided. The applicant must partner with an organization that delivers healthcare services or be a researcher based in a research unit embedded in a healthcare organization.
05/22/2026	Dana Foundation: Dana Education	$150,000	Dana Foundation	Community Engagement, Interdisciplinary, K-12, Neuroscience, Neuroscience and Society, Neuroscience Education	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 22, 2026 Amount: $150,000 (no indirects) Project period: 18 months Supports innovative neuroscience education projects that connect the science of the brain to real-world issues and everyday life. The goal is to help people of all ages better understand how neuroscience relates to societal challenges, ethics, policy, and human experiences, while encouraging interdisciplinary learning across science and non-science fields. Funded programs should use engaging and immersive educational approaches and be designed so they can be widely shared, adapted, and replicated in other communities. The program prioritizes initiatives that: (1) help the public apply neuroscience knowledge in daily life through informal education, (2) engage K-12 students with real-world neuroscience topics that inspire continued learning, and (3) support professionals with education that improves decision-making related to neuroscience in their fields.
05/22/2026	Dana Foundation: Dana NextGen	$150,000	Dana Foundation	Early Career, Interdisciplinary, Neuroscience, Neuroscience and Society, Workforce Training	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 22, 2026 Amount: $150,000 (no indirects) Project period: 18 months Supports training and workforce development for early-career scholars—from undergraduates to pre-tenure faculty—who work at the intersection of neuroscience and society. The program aims to cultivate interdisciplinary experts who integrate societal needs, ethics, and real-world considerations into neuroscience and neurotechnology research. Funded projects should emphasize cross-disciplinary collaboration between neuroscience and fields such as ethics, law, policy, and the humanities, and prioritize experiential learning that prepares trainees to address complex societal challenges. The program’s objectives are to: (1) train early-career researchers to critically examine the ethical, legal, and societal implications of neuroscience advances; (2) strengthen workforce development for careers within and beyond academia; and (3) foster collaborative, interdisciplinary approaches that combine neuroscience with non-science disciplines to solve complex societal problems. The funder will not fund neuroscience research without a non-science component.
05/22/2026	Dana Foundation: Dana Frontiers	$150,000	Dana Foundation	Community Engagement, Neuroscience, Neuroscience and Society	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: May 22, 2026 Amount: $150,000 (no indirects) Project period: 18 months Supports projects that strengthen the connection between neuroscience and society by promoting collaborative engagement with diverse communities. The program funds initiatives that bring together stakeholders—such as patients, researchers, clinicians, policymakers, ethicists, technologists, and the public—to ensure that neuroscience research and policy are shaped by a broad range of perspectives. Its goal is to build meaningful partnerships that help communities influence neuroscience and benefit from its advances. Funded projects focus on developing new engagement tools, piloting innovative approaches for community participation in research and policy, and supporting leaders who champion inclusive collaboration. The program seeks to build trust, embed community perspectives in neuroscience decision-making, and strengthen the ability of communities and organizations to address societal challenges related to neuroscience. The program does not fund projects focused mainly on one-way education or awareness about brain health or brain diseases. It also excludes projects that treat communities simply as audiences to be informed or as participants to improve research recruitment, rather than as true partners in collaboration and mutual learning. Additionally, projects that produce static outputs (such as reports, websites, or artistic works) without sustained, collaborative community engagement are not supported. Engagement limited only to academics or experts is also ineligible unless the project meaningfully connects with and benefits broader non-scientific communities.
06/01/2026	Alzheimer's Drug Discovery Foundation: ADDF-Harrington Scholar Program	$600,000	Alzheimer's Drug Discovery Foundation	Alzheimer's Disease, Dementia, Drug Discovery, IND-Enabling Studies	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: June 1, 2026 Amount: $600,000 Project period: Two years This award provides funding and project support by a team of pharmaceutical industry experts through a collaboration with the Alzheimer’s Drug Discovery Foundation (ADDF) and the Brain Health Medicines Centers of the Harrington Discovery Institute. Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. Projects must focus on developing novel therapeutic approaches—such as small molecules, antibodies, peptides, gene therapies, or oligonucleotides—to treat, prevent, or slow Alzheimer’s disease or related dementias. The program prioritizes innovative targets (e.g., proteostasis, cellular senescence, inflammation, mitochondrial function) and supports projects already in drug-development stages such as hit-to-lead optimization through IND-enabling studies, rather than early discovery work.
05/01/2026	Nemirovsky Engineering and Medicine Opportunity (NEMO) Prize	$125,000	Shelly and Ofer Nemirovsky	Biomedical Engineering, Health Sciences	Program Overview USC’s Office of the Senior Vice President for Health Affairs is soliciting proposals for the Nemirovsky Engineering and Medicine Opportunity (NEMO) Prize, a highly selective prize designed to bridge the critical gap between promising ideas and clinical breakthroughs. Two $125,000 NEMO Prizes will be awarded this funding cycle. Established through the generous support of Shelly and Ofer Nemirovsky, the NEMO Prize supports innovative, early-stage research at the intersection of health sciences and engineering that do not yet qualify for federal funding support and/or are not sufficiently mature enough for private investment. The primary goal of the NEMO Prize is to foster true health-engineering collaborations that advance transformative solutions to important clinical, health, or healthcare delivery challenges. The most competitive applicants will have lead investigators with both health science and engineering expertise. Both new and ongoing collaborative teams are invited to apply. Eligibility Faculty and research investigators from USC and Children’s Hospital Los Angeles are eligible to apply. Each proposal team must include at least one investigator with a primary appointment in a health science–related school or program and at least one investigator with a primary appointment in an engineering–related school or program. Both early-stage and seasoned investigators are eligible to apply; however, inclusion of an early-stage investigator is encouraged. Collaborators from other institutions may participate, but the lead investigator(s) must hold primary appointments at USC or CHLA. Justification for any external collaborators must be provided in the LOI. Full details here: https://drive.google.com/file/d/1qy6hE0MbHZ3shkSbXq6w05vX0qaDMO6r/view?usp=sharing Email contact: [email protected]
04/30/2026	Scott R. MacKenzie Foundation: Grant for Genetic Research	$500,000	Scott R. MacKenzie Foundation	Cancer, Diabetes, Genetics, Genomic Sequencing, Heart Disease, Lung Disease, Oncology	If you are interested in applying to the below opportunity, please contact Amy Cook at [email protected]. LOI due: April 30, 2026 Full application due: June 30, 2026 Amount: Variable up to $500,000 The Scott R. MacKenzie Foundation funds leading-edge human genetic research to advance cures for cancer, lung disease, diabetes and heart disease. Their mission is to provide funding to perpetuate genomic sequencing and genetic research that can impact humanity, improve quality of life, and transform the future health of communities.
07/01/2026	Focused Ultrasound Foundation: Preclinical Research Program	$150,000	Focused Ultrasound Foundation	Non-invasive Therapy, Preclinical, Translational, Ultrasound	If you are interested in applying to the below opportunity, please contact Amy Cook at [email protected]. LOI due: July 1, 2026 Amount: $150,000 (no indirects) Project period: one year The project must involve the use of non-invasive image-guided focused ultrasound to treat disease. Research priorities include translational studies, mechanisms of action and clinical indications across a wide variety of diseases. PI must be in a tenure track faculty position (academia). Full-time, non-tenure track faculty may be eligible but must have a letter from their institution stating that they are eligible to act as a PI. Postdocs and fellows are eligible for awards but must have a Co-PI that is in a tenure track faculty position.
04/28/2026	PCORI: Broad Pragmatic Studies	$12,000,000	PCORI	Comparative Clinical Effectiveness Research, Diabetes, Obesity, Patient-Centered Outcomes, Sickle Cell Disease, Urogynecological	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: April 28, 2026 Amount: $12,000,000 (plus 40% indirects) Project period: Five years Proposed research will compare existing treatments, services, or healthcare delivery approaches such as medications, screening methods, diagnostic tools, care models, or technologies to determine their relative benefits and harms. The goal is to generate evidence that helps patients, caregivers, clinicians, and healthcare systems make informed decisions that reflect patient needs and preferences. PCORI encourages submissions addressing four Special Areas of Emphasis: interventions for obesity treatment and management; prevention and treatment strategies for diabetes and prediabetes; improved prevention, diagnosis, and management of urogynecological and pelvic pain; and better pain management approaches for individuals living with sickle cell disease. Preferred study designs include randomized controlled trials, though natural experiments and observational studies may also be considered if well designed and adequately powered. All proposals must emphasize clinically meaningful, patient-valued outcomes and include strong engagement from patients and other stakeholders throughout the research process, consistent with PCORI’s partnership expectations. Applicants are also encouraged to evaluate patient-centered burdens and economic outcomes where relevant.
06/12/2026	Aqueduct Foundation and Horne Family Charitable Fund: Rachel Horne Prize	$40,000	Horne Family Charitable Fund	Associate Professor, Female Scientist, Mid-career, Multiple Sclerosis, Women	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due: June 12, 2026 Amount: $40,000 Project period: N/A The award recognizes a leading female scientist for their outstanding contribution to women's health-related research in MS. Applicants may self-nominate. Applicants must have an MD or PhD and have worked for more than 15 years at assistant professor level and, at the time of the application, hold the title of associate professor or professor. Applicants must commit to recording a special episode on the ECTRIMS podcast and presenting their work, including global remote meetings or face-to-face meetings organized by iWiMS.
05/16/2026	Triological Society/American College of Surgeons Clinician Scientist Development Awards	$400,000	Triological Society	Early Career, Head and Neck, Otolaryngology, Surgery, Triological	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due: May 16, 2026 Amount: $400,000 Project period: Five years The Triological Society and the American College of Surgeons combined competitive grant program provides supplemental funding to otolaryngologists-head and neck surgeons who have received a new NIH Mentored Clinical Scientist Development Award (K08/K23) or have an existing award with a minimum of 3 years remaining in the funding period as of October 1 of the application year. Applicants must be Associate Fellows or Fellows of the American College of Surgeons.
05/11/2026	Alzheimer's Drug Discovery Foundation: Accelerating Drug Discovery for Frontotemporal Degeneration	$300,000	Alzheimer's Drug Discovery Foundation	Drug Repurposing, Frontotemporal Dementia, In Vivo, Novel Therapeutics	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: May 11, 2026 Amount: $300,000 Project timeline: One year (option to extend with additional funding) All funding provided by the ADDF is through mission-related investments that require return on investment based upon milestones. Return on investment can include equity, convertible notes or royalties and are determined on a case-by-case basis. The RFP supports: Lead optimization of novel disease-modifying compounds, including medicinal chemistry refinement and in vitro ADME. In vivo testing of novel lead compounds, biologics, vaccines or repurposed drug candidates in relevant animal models for pharmacokinetics, dose-range finding, target engagement, in vivo efficacy, and/or preliminary rodent tolerability studies. This RFP does not support target identification, target validation, assay development, high-throughput and high-content screening. The strongest applications will test a compound that has met many or all of the following criteria: Chemical structures of hits and leads have been assessed for structural liabilities Novel composition of matter patents have been filed or plans to generate novel composition of matter intellectual property have been developed The strongest applications will test a repurposed or repositioned drug that has met many or all of the following criteria: The known side effects of the drug and how well they would be tolerated by the intended FTD population have been evaluated A supplier has been identified that will provide sufficient quantities of the drug or compound to complete the study aims Plans to develop novel IP around the repurposing/repositioning strategy have been considered Applications that include preclinical efficacy studies should: Provide data demonstrating blood-brain barrier penetration (if the intended target is in the CNS) Justify dose, route of administration, and regimen with in vivo PK/PD data. If this data is not yet available, a PK/PD study aim should be included in the proposal Include measures of target engagement in the proposed animal study design Include measures to assess off-target effects with the potential to interfere with behavioral outcome measures (e.g., sedation)
05/01/2026	Pew Charitable Trusts: Pew Biomedical Scholars – Limited Submission	$300,000	Pew	Biomedical Research, Early Career, Limited Submission	If you are interested in the following opportunity, please contact Carole King at [email protected]. Internal application deadline: May 1, 2026 Amount: $300,000 (includes 8% indirects) Project period: Four years This is a university-wide limited submission opportunity coordinated by the USC Provost’s Office. The process begins with an internal competition requiring a two-page research proposal and the PI’s CV. A faculty review committee will evaluate submissions and select the nominees who will be invited to advance to the external application stage with the sponsor. The internal deadline is pending. Candidates must hold a doctorate in biomedical sciences or a related field and run an independent lab with a full-time appointment as an assistant professor (research, adjunct, visiting, or instructor titles are not eligible). Applicants must not have established an independent lab before June 10, 2023 (excluding clinical training or parental leave), may apply no more than twice, must be institutionally nominated, and may not apply simultaneously to the Pew Scholars and Pew-Stewart Cancer Research programs. Proposals should reflect exceptional promise and highly creative, high-impact biomedical research (clinical trials are not supported), and selection is based on both the project’s strength and the investigator’s demonstrated independence and accomplishments. It is expected that Pew scholars will spend at least 80 percent of their time on research.
05/01/2026	Huo Family Foundation: Effects of the Usage of Digital Technology on Brain Development, Social Behaviors and Mental Health in Children and Young People - Junior Faculty	$688,500	The Huo Family Foundation	Brain Development, Digital Technology, Early Career, Junior Faculty, Mental Health, Youth	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application due May 1, 2026 Amount: $688,500 (includes 12.5% indirects) Project period: Three years The Huo Family Foundation invites junior faculty research grant applications to support early-career lecturers or assistant professors in developing independent research programs and leading projects or teams. Proposals must address the impact of digital technology use and exposure on brain development, social behavior, and the mental health and well-being of children and young people. Grant funds are not to be used to support the lead applicant’s salary. This opportunity excludes funding for new epidemiological cohorts, clinical service reorganization, animal studies, and systematic reviews. It also does not support projects involving digital technologies for mental health treatment or education, or randomized trials testing drugs, medical devices, diagnostics, or mental health intervention apps.
05/01/2026	Huo Family Foundation: Effects of the Usage of Digital Technology on Brain Development, Social Behaviors and Mental Health in Children and Young People – Early Career Fellowship	$526,000	The Huo Family Foundation	Brain Development, Digital Technology, Early Career, Mental Health, Post Doc, Youth	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application Due: May 1, 2026 Amount: $526,000 (includes 12.5% indirects) Project Period: Three years Proposals should address the broad topic of the effects of usage of and exposure to digital technologies on brain development and function (including physiological responses), social behavior and interactions, and the well-being and mental health of children and young people. Applicants must be postdoctoral researchers on the path to independence. Typically, the researchers must be within four years of completing PhD and without their first permanent position. This funding opportunity does not support new epidemiological cohorts, clinical service reorganization, animal studies, systematic reviews, or randomized trials involving drugs, medical devices, diagnostic procedures, or mental health intervention apps. It also excludes projects focused on developing or deploying digital technologies to deliver mental health treatment or educational learning.
05/29/2026	March of Dimes: Basil O’Connor Starter Scholar Research Awards	$150,000	March of Dimes	Early Career, Mid-career, Newborns, Postpartum, Pregnancy, Preterm Birth, Translational Research	If you are interested in any of the following opportunities, please contact Carole King at [email protected]. Application due: May 29, 2026 Amount: $150,000 Project period: Two years Supports research on serious medical conditions that affect maternal health during pregnancy and the health of mothers and newborns through the first year postpartum. Open to investigators who, at the time of award, are 4–9 years beyond completion of required clinical training for medical specialty board certification (MD or MD/PhD) or beyond receipt of their terminal degree (PhD). MD/PhD applicants must hold a full-time, tenure-track (or equivalent) faculty position at a U.S.-based institution. PhD applicants must have a primary or secondary appointment in a clinical department related to maternal or child health.
07/31/2026	Elevance Health Foundation: Maternal / Infant Health	$1,000,000	Elevance Health Foundation	Infant Health, Maternal Health, Maternal Morbidity	If you are interested in the following opportunity, please contact Carole King at [email protected]. Application due: July 31, 2026 Amount: Approximately $1,000,000 (15% indirects). Amount is not specified by the funder. Project period: Up to three years Grant funding for programs that improve maternal/ infant health, target disparities, address social needs, and remove barriers to care throughout the pregnancy journey—from pre-conception support to postnatal care for mothers and babies. Proposed programs should support one or more of the following goals: Reducing disparities in pre-term birth rates Reducing disparities in severe maternal morbidity (SMM) incidence Improving maternal/infant health outcomes Priority consideration will be given to programs that advance whole-person health through culturally responsive, trust-building interventions that address health-related social needs, demonstrate measurable outcomes, and offer innovative, scalable solutions.
04/28/2026	PCORI: Addressing Sensory Health Needs Across the Lifespan	$12,000,000	PCORI	Balance, Hearing, Mental Health, Senses, Sensory health conditions, Vision	If you are interested in this opportunity, please contact Carole King at [email protected]. LOI due: April 28, 2026 Budget: $12 million (plus 40% indirects) Project period: five years Sensory health conditions affect one or more sensory systems including vision, hearing, smell, touch, taste and balance and can arise across the lifespan. These conditions impact communication, mobility, access to information and quality of life, with significant disparities in access to care and outcomes. Sensory conditions are linked to increased mortality, cognitive decline and poor mental health, underscoring the need for timely screening, coordinated care and support services. This PCORI funding announcement seeks patient-centered comparative effectiveness research (CER) to address evidence gaps in screening, treatment, care coordination and support services for individuals with sensory health conditions and their care partners. PCORI encourages applications addressing: (1) improved screening and early detection, particularly in underserved communities; (2) treatments and care models that enhance access and coordination across health systems; and (3) support services that address mental health and stigma using patient- and family-centered, interdisciplinary approaches. Applicants are strongly encouraged to propose individual- or cluster-randomized controlled trials; however, well-specified natural experiments and well-designed observational studies will also be considered.
05/04/2026	Winn Career Development Award for Early-stage Investigator Physicians	$120,000	Bristol Myers Squibb	Career Development	Program Goal: This rigorous two-year program supports the career development of early-career investigator-physicians through structured education and mentorship on community-oriented clinical trial design and implementation. Through this work we ensure treatments developed are safe and effective for all who will use them and that more communities have access to the latest advances in medicine. Eligibility: Must have a demonstrated commitment to improving patient participation in clinical trials. Must be a physician (MD, DO, or international equivalent) AND have an active US medical license. Must be a US Citizen or Lawful Permanent Resident. Must focus on one of the following clinical research areas: cancer, cardiovascular and cardiometabolic diseases, and neuropsychiatry. Must currently be in the first to eighth year of a full-time clinical faculty appointment. Contact: Direct questions to [email protected]
09/14/2026	Alzheimer's Drug Discovery Foundation: Prevention	$5,000,000	Alzheimer's Drug Discovery Foundation	Alzheimer's, Alzheimer's Prevention, Human Studies	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: September 14, 2026 Budget: $5,000,000 (no indirects) Project period: Multi-year Funds human studies on precision prevention, combination therapies, and comparative effectiveness to reduce Alzheimer’s and related dementia risk. Eligible studies target primary or secondary prevention populations, focus on modifiable risk factors, and measure outcomes such as cognition or biomarkers. Lifestyle-only interventions are excluded, but combinations with drugs, supplements, or devices are eligible. Priority goes to novel or repurposed therapeutics with strong commercial or IP potential.
09/14/2026	Alzheimer's Drug Discovery Foundation: Neuroimaging and CSF Biomarker	$600,000	Alzheimer's Drug Discovery Foundation	Alzheimer's, Biomarkers	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: September 14, 2026 Budget: $600,000 (no indirects) Project period: one year This RFP aims to further develop and validate established biomarkers with clear clinical value in Alzheimer’s disease and related dementias. It prioritizes biomarkers with a defined context of use, clear advantages over existing options, and a pathway to commercialization or clinical application, focusing on novel PET ligands, CSF biomarkers, innovative MRI approaches, and new measures of functional activity such as EEG.
09/14/2026	Alzheimer's Drug Discovery Foundation: Drug Development	$5,000,000	Alzheimer's Drug Discovery Foundation	Alzheimer's, Drug Discovery	If you are interested in the following opportunity, please contact Carole King at [email protected]. LOI due: September 14, 2026 Amount: $5,000,000 (no indirects) Project Period: Multi-year Funds IND-enabling studies and early-phase clinical trials of promising drugs or devices for Alzheimer’s and related dementias, focusing on diverse, novel mechanisms tied to the biology of aging and emerging therapeutic areas. Anti-amyloid and cholinesterase inhibitor approaches are excluded. Up to $5,000,000 based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Payment structure will be negotiated and based on milestone achievements and recruitment.